Your session is about to expire
← Back to Search
Fluoride Toothpaste
ClōSYS® Sensitive Fluoride Toothpaste for Gum Disease
Phase 2
Waitlist Available
Research Sponsored by Rowpar Pharmaceuticals, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
Study Summary
This trial will measure how effective ClōSYS® Sensitive Fluoride Toothpaste and ClōSYS® Sensitive Rinse are in treating gingivitis and periodontitis.
Eligible Conditions
- Gum Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in Bleeding On Probing (BOP)
Changes in Clinical Attachment Level (CAL)
Changes in Modified Gingival Index (MGI)
+2 moreSecondary outcome measures
Adverse Events
Trial Design
1Treatment groups
Experimental Treatment
Group I: Treatment GroupExperimental Treatment2 Interventions
Participants with gingivitis or periodontitis (Stage I or II) brush with ClōSYS® Sensitive Fluoride Toothpaste twice daily and rinse with ClōSYS® Sensitive Rinse twice daily after brushing.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ClōSYS® Sensitive Fluoride Toothpaste
2021
Completed Phase 2
~60
Find a Location
Who is running the clinical trial?
Rowpar Pharmaceuticals, Inc.Lead Sponsor
4 Previous Clinical Trials
310 Total Patients Enrolled
Jaiprakash Shewale, Ph.D.Study DirectorRowpar Pharmaceuticals, Inc.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger